Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Takayuki Ikezoe's publication output changed over time?
ScholarIQpublication output · 2001–2023
Output declined50% over the shown period — from 2 works in 2001 to 1 in 2023.
2
1
1
1
1
1
1
1
1
1
2001200320052007201520192020202120222023
What are the most-cited papers on Takayuki Ikezoe?
ScholarIQmost cited works
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge, Corinne Frère, Jean M. Connors, Cihan Ay, Alok A. Khorana, Andrés J. Muñoz Martín, Benjamin Brenner, Ajay K. Kakkar, Hanadi Rafii, Susan Solymoss, Dialina Brilhante, Manuel Monréal, Henri Bounameaux, Ingrid Pabinger, James D. Douketis, Walter Ageno, Fernando Ajauro, Kamal R. Al-Aboudi, Thierry Alcindor, Thierry André, Pantep Angchaisuksiri, Darko Antić, Juan I. Arcelus, Eric Assénat, Kenneth A. Bauer, Ali Bazarbachii, Ilham Benzidia, Jan Beyer‐Westendorf, Viktoria Bitsadze, Dorit Blickstein, Mark Blostein, Isabel Bogalho, Barbara Bournet, Patricia Casais, Alain Carpentier, Gabriela Cesarman‐Maus, Joydeep Chakbrabartty, Hugo Clemente, J. Connault, Ludovic Doucet, C. Durant, Joseph Emmerich, Anna Falanga, Clemens Feistritzer, Carme Font, Charles W. Francis, Enrique Gallardo, Thomas Gary, Jean‐Christophe Gris, Cecilia Guillermo, A. Hij, Russel Hull, Takayuki Ikezoe, Luis Jara‐Palomares, Nigel S. Key, Jamilya Khrizroeva, Maral Koolian, Florian Länger, C. Le Hello, Ramón Lecumberri, Lai Heng Lee, Howard A. Liebman, Luisa Lopes Dos Santos, Duarte Machado, Isabelle Madelaine, А. D. Makatsariya, Mario Mandalà, Anthony Marayevas, Zora Marjanovic, Christine Marosi, Ellis Martin, Luis Meillón, E. Messas, António Moreira, Ahmet Muzaffer Demir, Arlette Ndour, Michel N'Guessan, Remedios Otero, Vanessa Pachón Olmos, Ana Pais, Florian Posch, Matthias Preusser, H. Riess, Marc Righini, Cynthia Rothschild, André Roussin, José Antonio Rueda-Camino, Pedro Ruiz‐Artacho, Sanjith Saseedharan, Ali Shamseddine, Gerald A. Soff, Hans Stricker, Vicky Tagalakis, Alì Taher, Toussaint Toutou, Javier Trujillo‐Santos, Stéphane Villiers, Raymond Wong, Norizaku Yamada
The Lancet Oncology. 2019660 CitationsOPEN ACCESS
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
Dominique Farge, Corinne Frère, Jean M. Connors, Alok A. Khorana, Ajay K. Kakkar, Cihan Ay, Andres Muñoz, Benjamin Brenner, Pedro Henrique Prata, Dialina Brilhante, Darko Antić, Patricia Casais, Cecilia Guillermo, Takayuki Ikezoe, Syed A. Abutalib, Luis Antonio Meillón‐García, Henri Bounameaux, Ingrid Pabinger, James D. Douketis, Walter Ageno, Fernando Ajauro, Thierry Alcindor, Pantep Angchaisuksiri, Juan I. Arcelus, Raquel Barba, Ali Bazarbachii, Audrey Bellesoeur, Okba Bensaoula, Ilham Benzidia, Darius Bita, Viktoria Bitsadze, Dorit Blickstein, Mark Blostein, Isabel Bogalho, A.A.G.S. Brandāo, Rodrigo T. Calado, Alain Carpentier, José Ceresetto, Rufaro S Chitsike, J. Connault, Catarina Jacinto Correia, Benjamin Crichi, Erich Vinícius De Paula, Ahmet Muzaffer Demir, Laure Deville, Ludovic Doucet, Vera Dounaevskaia, C. Durant, Ellis Martin, Joseph Emmerich, Anna Falanga, Carme Font, Enrique Gallardo, Thomas Gary, Filipe Gonçalves, Jean‐Christophe Gris, Hiromi Hayashi, A. Hij, Luis Jara‐Palomares, David Jiménez, J. Kh. Khizroeva, Michel N'Guessan, Florian Länger, C. Le Hello, Christine Le Maignan, Ramón Lecumberri, Lai Heng Lee, Zachary Liederman, Luisa Lopes dos Santos, Duarte Machado, А. D. Makatsariya, Alberto Maneyro, Zora Marjanovic, Serban Milhaileanu, Manuel Monréal, Sara Moráis, António Moreira, Mikio Mukai, Arlette Ndour, Luciana Correa Oliveira de Oliveira, Remedios Otero-Candelara, Maria Carolina Tostes Pintão, Florian Posch, Pascal Prilollet, Hanadi Rafii, Daniel Dias Ribeiro, Hanno Riess, Marc Righini, Helia Robert‐Ebadi, Cynthia Rothschild, André Roussin, José Antonio Rueda Camino, Pedro Ruiz‐Artacho, Gleb Saharov, Joana Santos, M. Sebuhyan, Ali Shamseddine, Galia Spectre, Alì Taher, Javier Trujillo‐Santos
The Lancet Oncology. 2022458 CitationsOPEN ACCESS
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
Jing Yang, Takayuki Ikezoe, Chie Nishioka, Taizo Tasaka, Ayuko Taniguchi, Yoshio Kuwayama, Naoki Komatsu, Kentaro Bandobashi, Kazuto Togitani, H. Phillip Koeffler, Hirokuni Taguchi, Akihito Yokoyama
Blood. 2007286 CitationsOPEN ACCESS
Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation
Rongqing Li, Xueqin Li, Jie Zhao, Fandong Meng, Chen Yao, Ensi Bao, Na Sun, Xin Chen, Wanpeng Cheng, Hui Hua, Xiangyang Li, Bo Wang, Hui Wang, Xiucheng Pan, Hongjuan You, Jing Yang, Takayuki Ikezoe
S2482500137. 2021164 CitationsOPEN ACCESS
Oridonin, a diterpenoid purified from<i>Rabdosia rubescens</i>, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways
Takayuki Ikezoe, Yang Yang, Kentaro Bandobashi, Tsuyako Saito, Shigeki Takemoto, Hisanori Machida, Kazuto Togitani, H. Phillip Koeffler, Hirokuni Taguchi
S48437117. 2005152 CitationsOPEN ACCESS
Related on ScholarIQ
Fukushima Medical University
Institution
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Paper
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
Paper
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo
Paper
Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidation
Paper
Oridonin, a diterpenoid purified from<i>Rabdosia rubescens</i>, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways
Paper